
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 993 | 1039 | 1145 | 1528 | 1997 |
Fund Return | 4.3% | -0.72% | 3.91% | 4.62% | 8.84% | 7.16% |
Place in category | 544 | 657 | 526 | 346 | 153 | 97 |
% in Category | 61 | 75 | 60 | 50 | 30 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund A DIST EUR | 9.44B | 1.04 | 15.43 | 18.80 | ||
Global Technology Fund E Acc EUR | 1.18B | 0.91 | 14.57 | 17.92 | ||
Global Technology Fund Y Acc EUR | 1.87B | 1.17 | 16.42 | 19.79 | ||
Global Technology Fund Y DIST EUR | 549.25M | 1.17 | 16.42 | 19.79 | ||
Fidelity Global Technol A-Acc-EUR | 2.88B | 1.02 | 15.44 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund A2e | 6.66B | 7.33 | 5.11 | 7.17 | ||
LU1960219571 | 1.34B | 7.48 | 6.14 | - | ||
World Healthscience Fund E2e | 2.18B | 7.24 | 4.59 | 6.64 | ||
LU2112291799 | 751.26M | 7.35 | 5.12 | - | ||
World Healthscience Fund C2e | 391.33M | 7.12 | 3.81 | 5.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boston Scientific | US1011371077 | 8.25 | 100.05 | -1.18% | |
UnitedHealth | US91324P1021 | 8.12 | 523.20 | +0.02% | |
Thermo Fisher Scientific | US8835561023 | 6.01 | 489.06 | +1.26% | |
Eli Lilly | US5324571083 | 5.68 | 818.22 | +1.61% | |
Stryker | US8636671013 | 5.11 | 377.46 | +1.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review